Beigene (ONC) SEC Filings & 10K Form

Beigene logo
$219.67 -3.83 (-1.71%)
As of 04:00 PM Eastern

Recent Beigene SEC Filings

DateFilerForm TypeView
02/06/2025
3:44 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wang Xiaodong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:02 PM
BeiGene, Ltd. (Filer)
Beigene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
4:08 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wang Xiaodong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
5:02 AM
BeiGene, Ltd. (Filer)
Beigene (Filer)
Form 10-K/A
01/07/2025
3:18 PM
BeiGene, Ltd. (Subject)
Beigene (Subject)
Wang Xiaodong (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/23/2024
5:05 AM
BeiGene, Ltd. (Filer)
Beigene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2024
4:02 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
OYLER JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
4:18 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wang Xiaodong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
8:25 PM
667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
8:30 PM
BAKER BROS. ADVISORS LP (Filed by)
BeiGene, Ltd. (Subject)
Beigene (Subject)
Form SC 13D/A
12/10/2024
7:19 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wu Xiaobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:26 PM
BeiGene, Ltd. (Subject)
Beigene (Subject)
Wang Xiaodong (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
5:02 AM
BeiGene, Ltd. (Filer)
Beigene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
8:48 PM
667, L.P. (Reporting)
BeiGene, Ltd. (Subject)
Beigene (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/09/2024
8:48 PM
Baker Brothers Life Sciences LP (Reporting)
BeiGene, Ltd. (Subject)
Beigene (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2024
8:45 PM
BeiGene, Ltd. (Subject)
Beigene (Subject)
HHLR ADVISORS, LTD. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2024
3:31 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wang Xiaodong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
3:23 PM
BeiGene, Ltd. (Subject)
Beigene (Subject)
Wang Xiaodong (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
3:23 PM
BeiGene, Ltd. (Subject)
Beigene (Subject)
Wang Xiaodong (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2024
3:39 PM
BeiGene, Ltd. (Subject)
Beigene (Subject)
OYLER JOHN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2024
5:03 AM
BeiGene, Ltd. (Filer)
Beigene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
5:05 AM
BeiGene, Ltd. (Filer)
Beigene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
5:29 PM
BeiGene, Ltd. (Filed by)
Beigene (Filed by)
LEAP THERAPEUTICS, INC. (Subject)
Form SC 13D/A
10/31/2024
4:40 PM
BeiGene, Ltd. (Filed by)
Beigene (Filed by)
LEAP THERAPEUTICS, INC. (Subject)
Form SCHEDULE 13D/A
10/28/2024
5:05 AM
BeiGene, Ltd. (Filer)
Beigene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2024
4:48 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
OYLER JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2024
3:23 PM
BeiGene, Ltd. (Subject)
Beigene (Subject)
OYLER JOHN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/08/2024
3:24 PM
BeiGene, Ltd. (Subject)
Beigene (Subject)
OYLER JOHN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2024
6:13 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Lee Chan Henry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
6:16 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Sharp Shalini (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/02/2024
6:21 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Sharp Shalini (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
5:29 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wang Lai (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
3:27 PM
BeiGene, Ltd. (Subject)
Beigene (Subject)
Lee Chan Henry (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/30/2024
5:02 AM
BeiGene, Ltd. (Filer)
Beigene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2024
5:12 AM
BeiGene, Ltd. (Filer)
Beigene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
4:25 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wu Xiaobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
3:40 PM
BeiGene, Ltd. (Subject)
Beigene (Subject)
Wu Xiaobin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2024
4:40 PM
Ball Titus B. (Reporting)
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
4:41 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wu Xiaobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
3:19 PM
BeiGene, Ltd. (Subject)
Beigene (Subject)
Wu Xiaobin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/29/2024
6:29 AM
BeiGene, Ltd. (Filer)
Beigene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
5-Second Trump Clip will Give You Chills (Ad)

President Trump's prediction is about to become a reality... Opening a rare window of opportunity for you to accelerate your retirement during the first 100 days of his administration.

Click here now to get the details because you must act before January 20th.
08/27/2024
3:30 PM
BeiGene, Ltd. (Subject)
Beigene (Subject)
OYLER JOHN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2024
4:27 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wang Xiaodong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:17 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Rosenberg Aaron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
6:32 AM
BeiGene, Ltd. (Filer)
Beigene (Filer)
Form S-4
Registration statement under Securities Act of 1933  
08/07/2024
5:04 AM
BeiGene, Ltd. (Filer)
Beigene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
5:07 AM
BeiGene, Ltd. (Filer)
Beigene (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2024
4:06 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Lee Chan Henry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2024
4:23 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Rosenberg Aaron (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/18/2024
5:40 AM
BeiGene, Ltd. (Filer)
Beigene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2024
4:05 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wang Julia Aijun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:18 PM
BeiGene, Ltd. (Subject)
Beigene (Subject)
Wang Julia Aijun (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/26/2024
4:22 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
OYLER JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2024
4:24 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wu Xiaobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2024
4:25 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wang Lai (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2024
4:26 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wang Julia Aijun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
3:30 PM
BeiGene, Ltd. (Subject)
Beigene (Subject)
OYLER JOHN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2024
3:19 PM
BeiGene, Ltd. (Subject)
Beigene (Subject)
Wang Julia Aijun (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2024
3:23 PM
BeiGene, Ltd. (Subject)
Beigene (Subject)
Wu Xiaobin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2024
3:25 PM
BeiGene, Ltd. (Subject)
Beigene (Subject)
Wang Lai (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/20/2024
4:27 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
OYLER JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
4:24 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Lee Chan Henry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
4:25 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wu Xiaobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
4:25 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wang Lai (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
4:26 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wang Julia Aijun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
3:50 PM
BeiGene, Ltd. (Subject)
Beigene (Subject)
Wang Lai (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
3:50 PM
BeiGene, Ltd. (Subject)
Beigene (Subject)
Wang Lai (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
3:53 PM
BeiGene, Ltd. (Subject)
Beigene (Subject)
OYLER JOHN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
3:57 PM
BeiGene, Ltd. (Subject)
Beigene (Subject)
Wang Julia Aijun (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2024
4:01 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
BRANDICOURT OLIVIER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:02 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Dugan Margaret (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:03 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Lee Chan Henry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:03 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wang Lai (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:04 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Wu Xiaobin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
4:05 PM
Ball Titus B. (Reporting)
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:31 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Yi Qingqing (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
4:23 PM
BeiGene, Ltd. (Filer)
Beigene (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/05/2024
3:35 PM
BeiGene, Ltd. (Filer)
Beigene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2024
3:25 PM
BeiGene, Ltd. (Subject)
Beigene (Subject)
OYLER JOHN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/08/2024
5:06 AM
BeiGene, Ltd. (Filer)
Beigene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
5:09 AM
BeiGene, Ltd. (Filer)
Beigene (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2024
3:21 PM
BeiGene, Ltd. (Filer)
Beigene (Filer)
Form ARS
04/26/2024
3:16 PM
BeiGene, Ltd. (Filer)
Beigene (Filer)
Form DEF 14A
04/26/2024
6:15 AM
BeiGene, Ltd. (Filer)
Beigene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2024
3:13 PM
BeiGene, Ltd. (Filer)
Beigene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2024
3:27 PM
BeiGene, Ltd. (Filer)
Beigene (Filer)
Form PRE 14A
04/11/2024
5:01 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
OYLER JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
3:21 PM
BeiGene, Ltd. (Subject)
Beigene (Subject)
OYLER JOHN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/26/2024
4:26 PM
Ball Titus B. (Reporting)
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/20/2024
3:10 PM
BeiGene, Ltd. (Filer)
Beigene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2024
4:23 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
OYLER JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Bill Gates’ is about to mint millionaires (again) with Stargate. (Ad)

This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.

Click here and I’ll tell you everything you need to know.
03/13/2024
4:04 PM
BeiGene, Ltd. (Issuer)
Beigene (Issuer)
Glazer Donald W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
5:01 AM
BeiGene, Ltd. (Filer)
Beigene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2024
5:16 AM
BeiGene, Ltd. (Filer)
Beigene (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/26/2024
5:02 AM
BeiGene, Ltd. (Filer)
Beigene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ONC) was last updated on 2/10/2025 by MarketBeat.com Staff
From Our Partners